We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$38.9B
1-Year Est. Return
28.51%
This Fund
S&P 500
This Quarter
Est. Return
+14.95%
1 Year Est. Return
+28.51%
3 Year Est. Return
+113.74%
5 Year Est. Return
+119.24%
10 Year Est. Return
+611.73%
AUM
$38.9B
AUM Growth
+$3.48B
(+9.8%)
Cap. Flow
-$847M
Cap. Flow
% of AUM
-2.18%
Top 10 Holdings %
Top 10 Hldgs %
22.43%
Holding
846
New
241
Increased
167
Reduced
189
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$820M |
| 2 |
Arista Networks
ANET
|
+$497M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$421M |
| 4 |
Spotify
SPOT
|
+$370M |
| 5 |
Meta Platforms (Facebook)
META
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.48B |
| 2 |
NVIDIA
NVDA
|
+$925M |
| 3 |
Amazon
AMZN
|
+$657M |
| 4 |
Robinhood
HOOD
|
+$618M |
| 5 |
Cisco
CSCO
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.88% |
| 2 | Industrials | 13.79% |
| 3 | Healthcare | 11.67% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Miscellaneous | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARTV
551
Artiva Biotherapeutics
ARTV
$342M
| $2.65M | 0.01% |
273,615
+173,615
| +174% | +$1.58M |
|
|
ACOG
552
Alpha Cognition
ACOG
$184M
| $2.64M | 0.01% |
365,000
| – | – |
|
553
BioNTech
BNTX
$24.7B
| $2.63M | 0.01% |
28,279
-48,671
| -63% | -$4.58M |
|
554
argenx
ARGX
$60B
| $2.61M | 0.01% |
+2,811
| New | +$2.32M |
|
555
Regencell Bioscience
RGC
$3.05B
| $2.54M | 0.01% |
+416,261
| New | +$10M |
|
556
Interactive Brokers
IBKR
$40.4B
| $2.51M | 0.01% |
+28,841
| New | +$2.4M |
|
557
Align Technology
ALGN
$10.4B
| $2.5M | 0.01% |
+14,845
| New | +$2.58M |
|
558
Intercontinental Exchange
ICE
$86.6B
| $2.5M | 0.01% |
20,302
-243,221
| -92% | -$36.5M |
|
|
LENZ
559
LENZ Therapeutics
LENZ
$123M
| $2.49M | 0.01% |
438,882
-24,613
| -5% | -$198K |
|
|
EPRX
560
Eupraxia Pharmaceuticals
EPRX
$529M
| $2.48M | 0.01% |
375,000
| – | – |
|
561
Coherus Oncology
CHRS
$175M
| $2.43M | 0.01% |
1,733,234
-516,766
| -23% | -$844K |
|
562
Aligos Therapeutics
ALGS
$34.4M
| $2.38M | 0.01% |
412,000
| – | – |
|
|
KLRS
563
Kalaris Therapeutics
KLRS
$69.5M
| $2.33M | 0.01% |
572,687
| – | – |
|
|
FRBT
564
Forbright Inc
FRBT
$897M
| $2.29M | 0.01% |
+125,000
| New | +$2.26M |
|
|
QXO
565
QXO Inc
QXO
$12.9B
| $2.14M | 0.01% |
+123,834
| New | +$2.3M |
|
566
Quanta Services
PWR
$97.6B
| $2.12M | 0.01% |
2,947
-89,026
| -97% | -$60.9M |
|
|
AGIG
567
Abundia Global Impact Group
AGIG
$59.2M
| $2.09M | 0.01% |
2,124,510
-1,250,865
| -37% | -$1.42M |
|
|
SUJA
568
Suja Life Inc
SUJA
$205M
| $2.03M | 0.01% |
+200,000
| New | +$2.69M |
|
|
EXYN
569
Exyn Technologies
EXYN
$18.4M
| $2.01M | 0.01% |
+387,000
| New | +$2.24M |
|
570
The Kraft Heinz Company
KHC
$28B
| $1.97M | 0.01% |
+83,322
| New | +$1.92M |
|
|
REA
571
Rare Earths Americas Inc
REA
$220M
| $1.93M | 0.01% |
+126,032
| New | +$2.49M |
|
|
SVIA
572
Silvia, Inc. Common Stock
SVIA
$346M
| $1.93M | 0.01% |
1,250,000
| – | – |
|
|
TSSI
573
TSS Inc
TSSI
$279M
| $1.91M | ﹤0.01% |
+155,594
| New | +$2.1M |
|
|
PXED
574
Phoenix Education Partners
PXED
$932M
| $1.9M | ﹤0.01% |
57,696
-185,859
| -76% | -$5.55M |
|
575
Larimar Therapeutics
LRMR
$319M
| $1.88M | ﹤0.01% |
617,211
| – | – |
|
Similar funds
Alyeska Investment Group's Q2 2026 Portfolio in Review
As of Q2 2026, Alyeska Investment Group held 846 positions worth $38.9B, up 9.8% from $35.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Alyeska Investment Group's Q2 2026 filing shows 241 new, 167 increased, 189 reduced and 194 closed positions. Its largest new stake was Salesforce: 4,662,005 shares worth $730M. The largest sale was Micron Technology, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.
- Alyeska Investment Group's largest Q2 2026 buy was Salesforce: 4,662,005 shares worth $730M.
- Alyeska Investment Group added most to CoreWeave in Q2 2026, an estimated $421M increase.
- Alyeska Investment Group's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $1.48B.
- Alyeska Investment Group fully exited Cisco in Q2 2026, selling an estimated $334M.
- Alyeska Investment Group's ten largest holdings make up 22% of its $38.9B portfolio in Q2 2026.
- Alyeska Investment Group opened 241 new positions and closed 194 in Q2 2026.
- Alyeska Investment Group's portfolio value rose 9.8% quarter-over-quarter to $38.9B.
Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.